Many cancer patients may need a sequential one-two punch of immunotherapies (IMAGE)

La Jolla Institute for Immunology

Many cancer patients may need a sequential one-two punch of immunotherapies

Caption

Anti-PD-1 cancer immunotherapies boost the body's cancer-fighting T cells, but in many patients, suppressive Tfr cells bring that progress to a grinding halt.

Credit

La Jolla Institute for Immunology

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.